PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go:
Extended
investment:
£295,000
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go:
Extended
investment:
Withheld
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go:
TBC
investment:
£127,001
Carverter is a technology platform that enables customers to find and lease a hybrid or Electric Vehicle (EV). The company cites data pointing out the UK government's ban on the sale of petrol and diesel only cars after 2030. It also argues about changing car preferences, with 78% of consumers considering leasing to access an EV. Carverter aims to capture this audience and grow its business. The company uses its algorithm to bring together over 32 million data points across its three tools, namely Carvert, Carwizard, and Browse, to help users find their choice of hybrid/EV. Carverter has partnered with renowned entities like WPP, Arval, Microsoft & ITV to boost its business. It will use 10% of the investment on hiring staff, 20% towards rolling out its services across 22 European countries via Arval, and 70% on an advertising multiplier deal with the UK's largest commercial broadcaster, ITV, and WPP.
days to go:
Expired
investment:
£2,324,693
Intelligent Health aim to get the whole community active by providing games and incentives such as ''beat the street''. By providing schools and communities with friendly competition to walk and cycle more by tapping their cards on ''beat boxes'', and with prizes and league tables on offer, Intelligent health are bringing communities together.
days to go:
Expired
investment:
£700,000
Arc's aim is to become the market leader in electrical recreational vehicles by using licensed battery automotive technology as the base. The company was born out of Jaguar Land Rover’s White Space. Since its pre-launch, the ‘Vector’ has attracted global interest with over 590 news articles covering its release across 55 countries. Arc also witnessed over 130 sales inquiries in relation to the limited 399 units which it is planning to produce. The company is on a mission of creating vehicles that challenge the environment while protecting it.
days to go:
Expired
investment:
£1,067,420
A new form of electric transport in the bike industry with the use of an affordable and simple conversion kit. Swytch have developed a kinetically rechargeable add-on for existing bikes to convert them into eBikes for a range of up to 50 miles. Funding will result in additional units being manufactured and sold at a 70% margin. The products are available online and currently via 20 independent bike dealers, with over 100 more waiting on stock.
days to go:
Expired
investment:
£349,356
Future You Cambridge is a company that sells clinically proven health supplements directly to consumers. Since its launch in 2016, it has sold products to over 100,000 customers. The company's Lactolycopene product received a patent in December 2017 and its Fertility+ product was also covered by the European Journal of Nutrition in a clinical paper and was shown to have resulted in a 40% increase in male fertility. The company's offerings now stand at 24 products, including the popular CBD product and its first product for pets, Curcupet-K9. Additionally, the company won the 2018 Cambridge Service Excellence and Independent High Growth Business of the Year Awards and has 5-star ratings on Trustpilot. They will use the investment to scale up direct advertising campaigns, expand its product range by more than 10 new products, and invest in their website to make it more intuitive.
days to go:
Expired
investment:
£655,011
By combining fitness with fashion, art and design, BLOK has become a major competitor of boutique class-based gyms within London. BLOK has appeared on Britain's Next Top Model, as well as working with global stars including Anthony Joshua and Jordan Dunn.
days to go:
Expired
investment:
£891,790
Angels on the Park is a nursery opening in East London that provide flexible childcare, extended their operating hours and arrange babysitting in the family home.
(EIS pending) (SEIS Pending)
days to go:
Expired
investment:
£61,450
